Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalia Burzyn

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|May 23, 2008
Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infectionGabriel Cabrera, Dalia Burzyn, Juliana Mundiñano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell numberGabriela Lombardi, Dalia Burzyn, Juliana Mundiñano, et al.
Cell|December 10, 2013
A special population of regulatory T cells potentiates muscle repairDalia Burzyn, Wilson Kuswanto, Dmitriy Kolodin, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
Science (New York, N.Y.)|August 15, 2015
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cellsEsen Sefik, Naama Geva-Zatorsky, Sungwhan Oh, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
A versatile platform for generating engineered extracellular vesicles with defined therapeutic propertiesKevin Dooley, Russell E McConnell, Ke Xu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Virology|May 23, 2008
Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infectionGabriel Cabrera, Dalia Burzyn, Juliana Mundiñano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell numberGabriela Lombardi, Dalia Burzyn, Juliana Mundiñano, et al.
Cell|December 10, 2013
A special population of regulatory T cells potentiates muscle repairDalia Burzyn, Wilson Kuswanto, Dmitriy Kolodin, et al.
Future Oncology (London, England)|January 6, 2026
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumorsEcaterina Dumbrava, Anna Minchom, Jason Henry, et al.
Science (New York, N.Y.)|August 15, 2015
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cellsEsen Sefik, Naama Geva-Zatorsky, Sungwhan Oh, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
A versatile platform for generating engineered extracellular vesicles with defined therapeutic propertiesKevin Dooley, Russell E McConnell, Ke Xu, et al.
Pageof 2